At a glance
ClinicalIndex Comparison RecordN/ACompleted· 84 enrolled
Drug / intervention
lycopene supplement +2 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Molecular Effects of Nutrition Supplements (MENS) Prostate Study
In Brief
A clinical study evaluating lycopene supplement, fish oil supplement, and 1 other intervention for Prostate Cancer. Completed, enrolled 84 participants across 1 site.
Detailed Summary
RATIONALE: The use of lycopene, a substance found in tomatoes, or omega-3 fatty acid nutritional supplements may keep cancer from growing in patients with prostate cancer. PURPOSE: This randomized clinical trial is studying lycopene to see how well it works compared to omega-3 fatty acids or a placebo in treating patients with stage I or stage II prostate cancer.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsProstate Cancer
CountriesUnited States
CollaboratorsNational Cancer Institute (NCI)
Timeline
N/ACompletedFinished
2003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartApr 2003
First PostedNov 2006
Primary CompletionJan 2008
TodayJul 2026
First PostedNov 22, 2006
Enrollment StartApr 1, 2003
Primary CompletionJan 1, 2008
TodayJul 2, 2026
Enrollment to primary: 4.8 yearsPosted 19.6 years ago
Interventions
lycopene supplementdietary
fish oil supplementdietary
Placeboother
placebos for lycopene and fish oil.